Falsified and substandard antimalarial medicines pose an immediate danger to vulnerable populations and could increase the threat of malaria drug resistance emerging and spreading. The major challenge in preventing the spread and distribution of poor quality medicines is the lack of accessible and reliable information on prevalence of poor quality medicines.
The WWARN Antimalarial Quality (AQ) Surveyor helps to respond to some of the critical gaps in information. This mapping tool delivers customised summaries of published reports of antimalarial medicine quality across regions and over time.
The AQ Surveyor
Includes published data describing the quality of malaria medicines
Provides customised summaries of antimalarial quality reports describing the quality of malaria medicines, techniques, assays and sampling – over time and location
Filters studies according to medicine, report type, collection type, medicine source and quality classification
Supports the effort of national and international organisations working to provide malaria patients with quality-assured, effective medicines